|
(単位:百万ドル)
|
2010/12
|
2011/12
|
2012/12
|
2013/12
|
2014/12
|
2015/12
|
2016/12
|
2017/12
|
2018/12
|
2019/12
|
2020/12
|
2021/12
|
2022/12
|
2023/12
|
2024/12
|
|
売上高
|
10,789
|
11,726
|
12,510
|
13,090
|
16,890
|
16,965
|
18,274
|
20,918
|
24,358
|
25,542
|
32,218
|
39,211
|
44,915
|
42,857
|
42,879
|
|
売上成長率(%)
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
売上原価
|
5,394
|
5,872
|
6,101
|
6,310
|
7,935
|
7,584
|
8,214
|
8,976
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
研究開発費
|
-
|
-
|
376
|
395
|
691
|
692
|
754
|
888
|
967
|
1,003
|
1,181
|
1,406
|
1,471
|
1,337
|
1,390
|
|
販売管理費
|
2,826
|
3,127
|
3,355
|
3,446
|
4,896
|
4,612
|
4,976
|
5,492
|
6,057
|
6,144
|
6,930
|
8,007
|
8,993
|
8,445
|
8,595
|
|
営業費用
|
9,524
|
10,481
|
11,028
|
11,481
|
14,387
|
14,629
|
15,825
|
17,950
|
20,575
|
20,948
|
24,424
|
29,183
|
36,522
|
35,998
|
35,542
|
|
営業利益
|
1,264
|
1,245
|
1,482
|
1,609
|
2,503
|
2,336
|
2,449
|
2,968
|
3,783
|
4,594
|
7,794
|
10,028
|
8,393
|
6,859
|
7,337
|
|
営業利益率 (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
経常(税引前)利益
|
-
|
1,126
|
1,269
|
1,319
|
2,087
|
1,936
|
2,023
|
2,429
|
3,262
|
4,070
|
7,225
|
8,841
|
7,835
|
6,298
|
7,037
|
|
経常(税引前)利益率(%)
|
-
|
9.61
|
10.15
|
10.08
|
12.36
|
11.41
|
11.08
|
11.61
|
13.39
|
15.93
|
22.43
|
22.55
|
17.44
|
14.7
|
16.41
|
|
法人税等合計
|
131
|
107
|
11
|
40
|
191
|
-44
|
-2
|
201
|
324
|
374
|
850
|
1,109
|
703
|
284
|
657
|
|
実効税率(%)
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
純利益
|
1,035
|
1,329
|
1,177
|
1,273
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
7,728
|
6,960
|
5,955
|
6,338
|
|
純利益率(%)
|
|
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
|
一株あたり利益
|
2.57
|
3.49
|
3.24
|
3.53
|
4.76
|
4.96
|
5.12
|
5.64
|
7.31
|
9.24
|
16.09
|
19.62
|
17.75
|
15.52
|
16.58
|
|
希薄化後一株あたり利益
|
2.53
|
3.46
|
3.21
|
3.48
|
4.71
|
4.92
|
5.09
|
5.59
|
7.24
|
9.17
|
15.96
|
19.46
|
17.63
|
15.45
|
16.53
|
|
配当性向(%)
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
一株あたり配当金
|
-
|
-
|
0.54
|
0.6
|
0.6
|
0.6
|
0.6
|
0.6
|
0.68
|
0.76
|
0.88
|
1.04
|
1.2
|
1.4
|
1.56
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
|
EBITDAマージン(%)
|
|
|
|
|
|
|
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|